REGENXBIO hiring Contract Clinical Outcomes Researcher- MPS • Remote (Work from Home) | Himalayas
REGENXBIORE

Contract Clinical Outcomes Researcher- MPS

REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy, utilizing its proprietary NAV® Technology Platform to develop a pipeline of AAV therapeutics for retinal, metabolic, and neurodegenerative diseases.

REGENXBIO

Employee count: 201-500

The opportunity:

As a Contract Clinical Outcomes Researcher- MPS, you will support the development and execution of clinical outcomes strategies for MPS (Mucopolysaccharidoses) programs, particularly in the areas of neurodevelopment, functional performance, and patient-reported outcomes. Serving as a subject matter expert, you’ll advise on study design, protocol development, and endpoint selection to help ensure patient- and regulatory-relevant outcomes. You’ll also contribute to cross-functional collaborations, support the development of training materials and study documents, and provide input on COA data analysis and dissemination.

What you'll be doing:

  • Support the development and implementation of clinical outcomes strategies for MPS programs, with a focus on neurodevelopment, functional performance, mobility, patient-reported outcomes (PROs), health-related quality of life, and healthcare resource utilization.
  • Provide input into the training and qualification process for site raters and offer guidance to help ensure consistency in administration and scoring across sites.
  • Contribute to the identification and recommendation of meaningful clinical endpoints—particularly in neurocognitive, behavioral, and functional domains—to support regulatory and patient-centered goals across early- and late-phase studies.
  • Serve as a subject matter expert on neurodevelopmental assessments, advising on study design, endpoint selection, and protocol development.
  • Collaborate with cross-functional teams including Clinical Science, Regulatory, Biostatistics, Patient Advocacy, Commercial, and Medical Affairs.
  • Support the design of evidence-generation strategies aligned with the broader medical strategy and access objectives for the program.
  • Liaise with Clinical Operations, CROs, and vendors to provide input on COA collection processes, helping ensure alignment with SOPs and ICH/GCP guidelines.
  • Contribute to the development and review of COA execution strategies, including training materials, translations, source documentation, and study specifications.
  • Review and provide feedback on project-related eCOA documentation throughout the project lifecycle.
  • Collaborate with Biostatistics on COA data analysis plans, offering recommendations for data outputs including tables and figures.
  • Work with Clinical Development and Medical Affairs to support the development and review of study reports, abstracts, and manuscripts related to COA content, and contribute to presentations for internal and external meetings or conferences.

What we're looking for:

  • Post-baccalaureate degree in a health field (e.g., Ph.D., PharmD, DPT) required.
  • Minimum 10 years relevant experience in industry positions as a contractor or employee.
  • Experienced in biopharmaceutical drug development including, clinical investigational protocols, implementation of protocols, interpretation of data, and interactions with regulatory bodies.
  • MPS or other lysosomal storage disorders experience preferred.
  • Knowledge of gene therapy preferred.
  • Demonstrates excellent presentation, verbal, and written communication skills; able to present information to diverse audiences in a clear and concise manner.
  • Has strong planning and organizational skills with ability to set priorities effectively and efficiently. Able to manage multiple tasks, projects, and stakeholders.
  • Has genuine empathy and compassion for patients and families and is committed to acting in the best interests of the patient community. Respects patient privacy.
  • Able to build rapport quickly, and cultivate trusting, collaborative relationships both internally and externally.
  • Is a self-starter and team player. Able to work collaboratively with others and influence towards common objectives. Promotes cross-functional collaboration and communication within organization. Inspires and motivates direct reports and team members.
  • Shows adaptability, flexibility, and willingness to work in a changing environment.

About the job

Apply before

Posted on

Job type

Contractor

Experience level

Mid-level

Location requirements

Open to candidates from all countries.

Hiring timezones

Worldwide

About REGENXBIO

Learn more about REGENXBIO and their company culture.

View company profile

REGENXBIO Inc. is a premier, clinical-stage biotechnology company dedicated to improving lives through the transformative potential of gene therapy. Established in 2009, the company has been a trailblazer in the development of adeno-associated virus (AAV) therapeutics, a sophisticated and innovative class of gene therapy medicines. REGENXBIO's core mission is to address severe diseases with significant unmet medical needs by developing and commercializing gene therapy products that can be administered directly into the body, or in vivo. The foundation of the company's pioneering work is its proprietary NAV® Technology Platform. This platform encompasses exclusive rights to a vast portfolio of over 100 novel AAV vectors, including AAV7, AAV8, AAV9, and AAVrh10. These vectors are engineered to be non-replicating viral delivery vehicles that are not known to cause disease, making them an ideal and safe mechanism for delivering functional genes to target cells and correcting underlying genetic defects.

The company's robust pipeline of investigational AAV Therapeutics is focused on a range of debilitating conditions, with a primary emphasis on retinal, metabolic, and neurodegenerative diseases. Key programs include ABBV-RGX-314, which is being developed in collaboration with AbbVie for the treatment of wet age-related macular degeneration (wet AMD) and diabetic retinopathy. Another significant candidate is RGX-202, aimed at treating Duchenne muscular dystrophy. Furthermore, REGENXBIO is advancing treatments for rare metabolic disorders such as Mucopolysaccharidosis Type II (MPS II) with RGX-121 and Mucopolysaccharidosis Type I (MPS I) with RGX-111. The company's comprehensive approach integrates in-house research and development with strategic licensing of its NAV® Technology Platform to a network of third-party licensees. This dual strategy allows REGENXBIO to expand the application of its technology across multiple therapeutic areas while advancing its own promising candidates through clinical trials and towards commercialization, with the ultimate goal of delivering one-time, curative treatments to patients worldwide.

Employee benefits

Learn about the employee benefits and perks provided at REGENXBIO.

View benefits

Paid Time Off

Eligible for paid time off.

Summer Hours

Offers flexible summer hours.

Life Insurance

Company-provided life insurance.

Health Insurance

Comprehensive health insurance coverage.

View REGENXBIO's employee benefits
Claim this profileREGENXBIO logoRE

REGENXBIO

View company profile

Similar remote jobs

Here are other jobs you might want to apply for.

View all remote jobs

3 remote jobs at REGENXBIO

Explore the variety of open remote roles at REGENXBIO, offering flexible work options across multiple disciplines and skill levels.

View all jobs at REGENXBIO

Remote companies like REGENXBIO

Find your next opportunity by exploring profiles of companies that are similar to REGENXBIO. Compare culture, benefits, and job openings on Himalayas.

View all companies

Find your dream job

Sign up now and join over 100,000 remote workers who receive personalized job alerts, curated job matches, and more for free!

Sign up
Himalayas profile for an example user named Frankie Sullivan